TY  - GEN
AU  - Rich,Sheldon J
AU  - Meyer,Christina
TI  - Shortcomings in pharmacy benefit forecasting--interferon beta products
SN  - 1083-4087
PY  - 2003///1210
KW  - Adjuvants, Immunologic
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Humans
KW  - Interferon beta-1a
KW  - Interferon-beta
KW  - Multiple Sclerosis
KW  - drug therapy
N1  - Publication Type: Comment; Letter
UR  - https://doi.org/10.18553/jmcp.2003.9.4.373
ER  -